Clinical Trial Update: Pomalidomide, Dexamethasone and Rituximab in Waldenstrom's Macroglobulinemia [Phase 1]

View source ↗

Summary

A Phase 1 trial of pomalidomide, dexamethasone, and rituximab in Waldenström's macroglobulinemia was terminated, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Waldenström Macroglobulinemia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Pomalidomide (Pomalidomide)
• Rituximab (rituximab)

Snippet

Sponsor: Steven P. Treon, MD, PhD | Conditions: Waldenstrom's Macroglobulinemia | Phase 1 | Status: TERMINATED | Results posted: 2016-07-25